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Abstract
In vertebrates, mitochondria are tightly preserved energy producing organelles, which sustain nervous system
development and function. The understanding of proteins that regulate their homoeostasis in complex animals is
therefore critical and doing so via means of systemic analysis pivotal to inform pathophysiological conditions
associated with mitochondrial deficiency. With the goal to decipher the role of the ATPase inhibitory factor 1 (IF1) in
brain development, we employed the zebrafish as elected model reporting that the Atpif1a−/− zebrafish mutant,
pinotage (pnttq209), which lacks one of the two IF1 paralogous, exhibits visual impairment alongside increased
apoptotic bodies and neuroinflammation in both brain and retina. This associates with increased processing of the
dynamin-like GTPase optic atrophy 1 (OPA1), whose ablation is a direct cause of inherited optic atrophy. Defects in
vision associated with the processing of OPA1 are specular in Atpif1−/− mice thus confirming a regulatory axis, which
interlinks IF1 and OPA1 in the definition of mitochondrial fitness and specialised brain functions. This study unveils a
functional relay between IF1 and OPA1 in central nervous system besides representing an example of how the
zebrafish model could be harnessed to infer the activity of mitochondrial proteins during development.
Introduction
The zebrafish (Danio rerio) represents a powerful model
system for studying vertebrate development and the
pathogenesis of human diseases (as reviewed in ref.1).
Recently, it has also been employed as a tool for mito-
chondrial genetic and pharmacological studies2,3. Mito-
chondrial defects are commonly observed in a wide
spectrum of human pathologies, such as cancer, diabetes
and neurodegeneration. As in humans and mammals, the
phenotypes observed in zebrafish include neuronal and
synapse loss4, alterations in brain activity5, aberrant motor
and sensory responses5, blood and vascular disorders6.
Mitochondrial disorders can be caused by either defective
mitochondrial bioenergetics or intracellular transport,
which can result in abnormal subcellular localization of
the organelle, increased production of reactive oxygen
species (ROS) or impaired OXPHOS activity7. The zeb-
rafish mitochondrial respiratory chain complexes have a
high degree of identity with the human counterparts and
their inhibition causes severe developmental defects,
ranging from morphological and physiological abnorm-
alities to embryonic arrest2. Brain development is tightly
regulated by the metabolic state of mitochondria whose
mass may change during neuronal differentiation. Indeed,
while a decrease in mitochondrial activity has been
observed as human embryonic stem cells (hESCs) differ-
entiate into neural stem cells (NSC)8, mitochondrial
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biogenesis increases during the maturation of NSCs into
motor neurons9. Trafficking of mitochondria is also cru-
cially involved in the formation of axons, dendrites and
synaptic connections10.
The F1Fo-ATPsynthase plays an important part in all
this. Physiologically, its activity regulates cellular ATP
provision11, mitochondrial ultrastructure12, Ca2+ hand-
ling and cell death13. Defects in the function and assembly
of the F1Fo-ATPsynthase, are observed in postnatal and
age-related neurometabolic disorders (i.e. Leigh syn-
drome, maternally inherited Leigh syndrome, Leber her-
editary optic neuropathy and neuropathy, ataxia, and
retinitis pigmentosa14), all of which characterized by
early-onset and motor and sensory neurological symp-
toms, such movement disorders and visual impairments15.
The activity of this enzyme is indeed involved in driving
synapse formation and sustaining physiological brain
activity, and its impairment associates with a decline in
both neuronal performance and plasticity16.
Aging processes are not exception as loss of mitochon-
drial inner membrane organization following disassembly
of F1Fo-ATPsynthase complexes is also described
17.
The ATPase inhibitory factor 1 (IF1), which is the most
characterized regulator of the F1Fo-ATPsynthase
18,19, binds
to the enzyme inhibiting its hydrolytic activity thereby
protecting cells from ATP depletion during de-energized
conditions18. A series of evidences suggests that, in cancer
cells, the deregulated, enhanced binding of IF1 to the F1Fo-
ATPsynthase activates oncogenic regulatory mechan-
isms20–22. IF1 though is mainly known for its protective role
from hypoxic/ischaemic damage in tissues with high-energy
demand, such as heart and brain23. However, its ubiquitous
expression and high degree of sequence conservation
underline a wider role, which has been recently associated
with the regulation of stem cell differentiation24, hepatic
cholesterol uptake25, haem synthesis6, cell proliferation and
programmed demise26,27.
IF1 expression is sustained in neurons
28, which highly
rely on oxidative metabolism, which is per se indicative of
a core role in energy provision, which is not reported in
astrocytes29. The upregulation of IF1 expression is notably
observed during brain preconditioning, involving adap-
tation of both mitochondrial metabolism30 and quality
control23,31–33. Equally, deregulation of IF1 activity could
harm these processes, leading to the onset of pathological
conditions. We therefore set to investigate this using the
Atpif1a−/− zebrafish mutant pinotage (pnttq209), which is
indeed lacking of the a gene type of the Atpif1 paralogues.
The zebrafish genome contains two copies of the Atpif1
gene, Atpif1a and Aatpif1b6, a duplication that is likely to
originate in teleosts34 and so encode for two proteins
with partially redundant functions6. We have recently
used the zebrafish mutant pnttq209 to study the involve-
ment of IF1 in haem synthesis reporting reduced rate of
ferrochelatase-dependent iron incorporation into proto-
porphyrin6 leading to decreased haem content and ery-
throcyte volume6. Whether IF1 expression affects other
systemic functions and organ physiology during devel-
opment is nonetheless unknown. Here we report that
alterations in IF1 expression lead to visual impairments in
both zebrafish larvae and mice providing evidences in
complex model systems of an underlying interplay
between IF1 and OPA1 in the definition of mitochondrial
homoestasis exploited during development and reflected
systemically.
Results
Reduced IF1 levels lead to increased apoptosis and
neuroinflammation in the brain and retina
The analysis of the effect of reduced IF1 levels on zeb-
rafish neurodevelopment started with an examination of
nervous system cell survival and proliferation during
embryogenesis in the pnttq209 mutant. Indeed, an imbal-
ance between proliferation and apoptosis leads to defec-
tive clonal expansion of progeny cells, abnormal organ
growth and functional impairments. For the purpose, we
first determined the number of apoptotic bodies in both
brain and retina of pnttq209 mutants and normal siblings
(Sbs) at 72 h post fertilisation (hpf).
Larvae were subjected to TUNEL staining prior to HuC/
D immunostaining to simultaneously visualize apoptotic
bodies and neuronal cells, respectively (Fig. 1a). The ana-
lysis, conducted with a confocal microscope, revealed an
increase in the number of apoptotic bodies in both brain
and retina of pnttq209 mutants (Fig. 1b), even though no
obvious differences in the pattern of the neuronal marker
HuC/D were observed between mutants and Sb (Fig. 1a).
Considering the increased rate of programmed cell
death observed in the pnttq209 mutants, we hypothesized
that this could lead to a neuroinflammatory response.
Therefore, we monitored the level of microglial activation
in both mutants and Sb. For the purpose, we employed
in situ hybridisation (ISH) of apolipoprotein E (apoE)
mRNA and neutral red (NR) vital dye staining35,36 to
visualize microglia in the pnttq209 zebrafish brain (Fig. 1c).
Interestingly, we found an increase in both apoE-positive
(Fig. 1d, g) and NR-positive (Fig. 1e, h) cells in the brain
and retina of pnttq209 larvae. Microglial cells did also
appear significantly larger (Fig. 1f), thus implying an
activated state37. Taken together, these data suggest the
induction of an inflammatory response in pnttq209 zebra-
fish as ablation of Atpif1a expression may lead to cell loss
and a neuroinflammatory phenotype in zebrafish.
IF1 loss causes visual impairment in pnt
tq209 zebrafish and
Atpif1−/− mice
Excessive, uncontrolled microglial activation is a major
cause of inflammation-mediated neurodegeneration38. As
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Fig. 1 (See legend on next page.)
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higher levels of apoptotic bodies were detected in both
brain and retina of pnttq209 mutants, and chronic neu-
roinflammation is frequently associated with retinal neu-
rodegeneration39, we decided to further explore the
phenotypic outcome of Atpif1a loss by assessing the visual
function in pnttq209 larvae. For this purpose, the optoki-
netic response (OKR) of pnttq209 and normal Sb zebrafish
larvae was measured. The OKR is the ocular movement
induced by changes in the visual surround, and is com-
monly used to obtain an accurate quantitative readout of
visual ability in zebrafish larvae40. At 72 hpf, the larval
OKR was assessed by counting the number of eye
movements under normal conditions or during constant
visual stimulation. Each record lasted 3min, and visual
stimulation was achieved by moving black and white
stripes around the test chamber (Fig. 2a). Remarkably, the
analysis revealed a different response to the moving
striped pattern between pnttq209 mutants and normal Sb.
Even though pnttq209 larvae did not show any noticeable
alteration under normal conditions, they were sig-
nificantly less sensitive to constant light changes in the
surrounding environment (Fig. 2b, c). This indicates that
Atpif1a deficiency is associated with mild vision impair-
ment, which affects the responsiveness of pnttq209 larvae
to visual stimuli.
To corroborate this finding, we monitored the visual acuity
in 4-month-old Atpif1−/− mice. This was investigated by
using the visual cliff apparatus, monitoring the propensity by
mice to step towards the platform side (safe choice) and
avoid the drop (Fig. 2d). Notably, the loss of Atpif1 correlated
with alterations in the spatial perception and a substantial
reduction in the number of positive choices was observed in
Atpif1−/− mice (Fig. 2e), a response that also characterizes
strains affected by retinal degeneration31.
The data collected so far confirm that Atpif1 contributes
to correct visual function in vertebrates. The protein can
therefore be ascribed among the mitochondrial factors
that play a role in the development and maintenance of
the neural retina, among which the dynamin-like protein
optic atrophy 1 (OPA1) is the most known37. Mutations
in the OPA1 gene that impair the expression or activity of
the protein are associated with hereditary optic neuro-
pathies related with mitochondrial dysfunction, such as
autosomal-dominant optic atrophy (ADOA)41,42. Inter-
estingly, although ubiquitously expressed throughout the
body, during embryonic development IF1 is significantly
upregulated in the retina of both zebrafish6 and mouse43,44.
Furthermore, IF1 shares a similar chronological expression
profile during development with OPA145 and recently we
described a functional relay between IF1 and OPA1, which
shields the latter from the processing mediated by the
Metalloendopeptidase OMA146.
In order to investigate whether the vision defects
detected in zebrafish and mice lacking IF1 expression were
related to OPA1 inactivation, we first monitored the levels
of OPA1 in the brain and retina of pnttq209 and normal Sb
zebrafish at 72 hpf. The analysis was carried out by whole-
mount immunofluorescence and revealed an extensive
decrease in the expression profile of the protein in both
brain (midbrain-hindbrain, in particular) and retina of
pnttq209 mutants when compared to Sb (Fig. 3a, b).
Despite this, no prominent differences in the eye mor-
phology (size and shape) were detected between pnttq209
and wild-type (WT) larvae (Fig. 3c, d), implying that
Atpif1a loss does not cause any major anatomical eye
defects, and that mainly affects the neural part of the
organ. To confirm this observation, the levels of both
OPA1 isoforms were quantified via western blotting in the
whole embryos (Fig. 3e, f). This analysis reports a decrease
in the levels of the profusion protein, which prevalently
affects the short isoforms. However, we should consider
that the samples were obtained from the whole pnttq209
larvae, entailing technical limitations in protein extraction
by homogenization.
(see figure on previous page)
Fig. 1 Apoptosis and microglial activation are increased in the CNS of pnttq209 larvae. a TUNEL assay (A, B) and HuC/D (C, D) immunostaining
of PTU-treated normal Sb and pnttq209 mutant zebrafish at 72 hpf to detect apoptotic cells and differentiated neurons, respectively. The merge
between the two fluorescent signals is shown in E and F. b Quantification of apoptotic bodies, detected with the TUNEL assay, in Sb and pnttq209
zebrafish, showing a significant increase in the total number of apoptotic bodies in the brain and retina of mutant larvae (number of apoptotic
bodies (TUNEL-positive puncta) in the brain, Sb: 31.10 ± 2.35, pnttq209: 57.53 ± 3.12; in the retina, Sb: 5.33 ± 0.85, pnttq209: 21.80 ± 1.52; results are
reported as mean ± S.E.M. (n= 15–20)). c apoE in situ hybridization (A, B) and NR staining (C–F) were carried out in PTU-treated, 72 hpf zebrafish to
visualise microglia. d, e Quantification of apoE-positive (d) and NR-positive (e) cells in the whole CNS. A significant increase in the number of
microglial cells characterizes pnttq209 zebrafish ((number of apoE-positive puncta, Sb: 13.10 ± 1.28, pnttq209: 25.20 ± 1.38; number of NR-positive puncta,
Sb: 17.50 ± 1.18, pnttq209: 23.13 ± 1.35; results are reported as mean ± S.E.M. (apoE: n= 10; NR: n= 24)). f Analysis of the size of NR puncta. pnttq209
zebrafish showed a significant increase in the size of microglia when compared to Sb (microglial area (NR-positive pixels), Sb: 210.45 ± 15.65, pnttq209:
379.35 ± 26.73; results are reported as mean ± S.E.M. (n= 15)). g, h Evaluation of the number of cells stained with apoE (g) and NR (h) in the brain and
retina, separately. The results demonstrate that, in pnttq209 larvae, the increase in microglial cell population is also extended to the retina ((number of
apoE-positive puncta in the brain, Sb: 4.40 ± 0.56, pnttq209: 9.60 ± 1.38; in the retina, Sb: 8.70 ± 1.58, pnttq209: 15.60 ± 1.73; number of NR-positive puncta
in the brain, Sb: 11.19 ± 1.10, pnttq209: 16.50 ± 1.21; in the retina, Sb: 5.44 ± 0.93, pnttq209: 7.94 ± 1.23; results are reported as mean ± S.E.M. (apoE: n= 10;
NR: n= 15)). FB forebrain, HB hindbrain, MB midbrain, R retina
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A tissue-specific analysis was instead obtained using
extracts from WT and Atpif1−/−mouse. In these, OPA1
isoforms have been monitored in the brain (frontal cor-
tex/hippocampus), optic nerve and liver homogenates
(Fig. 3g-j, SFigure 1a,b). Even in this case, the expression
of short and long OPA1 isoforms was downregulated
in Atpif1−/− mice (almost halved when compared to WT
mice). This data suggest that, even though Atpif1 defi-
ciency causes a tissue-specific phenotypic alteration
leading to visual impairment6,47, the physiological
OPA1 processing seems to be retained in each tissue
investiagated. Considering the close link between OPA1
loss-of-function and defects in optic nerve morphogen-
esis, which are a direct consequence of impaired mito-
chondrial function48, we further investigated the effect of
IF1 loss on mitochondrial respiratory capacity. For the
purpose, we evaluated the levels and assembly of mito-
chondrial respiratory chain complexes by two-
dimensional blue native/SDS gel electrophoresis. Mito-
chondrial bioenergetic efficiency and adaptive capacity
rely on the dynamic supramolecular organization of
respiratory chain complexes in supercomplexes (SCs) or
respirasomes. The analysis of the stoichiometric compo-
sition of mitochondrial respirasomes gives significant
information on the organelle bioenergetic homoeostasis.
We attempted to measure the relative levels of SCs in
extracts from WT and Atpif1−/− murine liver and brain,
as well as WT and IF1 knockdown human neuroblastoma
SHSY-5Y cells. The analysis revealed that IF1 expression
levels alters the respirasome assembly in both murine
Glass over the pattern
Glass only
Deep pattern seen through glass
Shallow side
Cliff
Deep side
e d 
pnttq209pnttq209
a b c 
CCD 
camera
Analysis of retinal 
movements
Rotating striped 
background
Fig. 2 Vision is impaired in zebrafish and mice lacking Atpif1. a Schematic representation of the device used to measure the OKR of zebrafish
larvae. b, c OKR in Sb and pnttq209 zebrafish at 72 hpf. While normal and mutant larvae have a comparable number of retinal movements in normal
conditions (b), the latter exhibit a significantly reduced response to visual stimulation, which was achieved by a rotating striped disc (c) (number of
retinal movements in normal conditions, Sb: 5.5 ± 1.85, pnttq209: 3.5 ± 1.58; with striped visual background, Sb: 7.75 ± 2.14, pnttq209: 1.40 ± 0.40; results
are reported as mean ± S.E.M. (n= 5)). d Model of the visual cliff apparatus. e Visual cliff test in WT and Atpif1−/− mice. The quantification of safe
choices (avoidance of the drop) indicates that visual acuity is mildly compromised in mutant mice (percentage safe choices, WT: 100.00 ± 0.00,
Atpif1−/−: 61.00 ± 1.73); results are presented as mean ± S.E.M. (n= 5))
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and human derived lines (S Figs. 1 and 2). Most notably,
differences appear prominent in the layout of the com-
plexes in which association between complexes I and III is
far less in extracts in which the Atpif1 gene is ablated or
the protein product downregulated. We also note an
overall reduction of the complex IV levels, which could
per se reduce the respiratory efficiency, as well as
favouring the accumulation of ROS and therefore trigger
apoptosis.
All this is nonetheless indicative of an underlying
mitochondrial phenotype associated with Atpif1 loss and
aberrant processing of OPA1, which could lead to the
defects in visual capacity observed in both zebrafish and
mice.
Analysis of locomotor ability in pnttq209 zebrafish
Based on the results described above, we examined
whether locomotion could also be affected by IF1 defi-
ciency due to axonal alterations in the caudal region of the
larvae. The number and morphology of spinal cord motor
axons were monitored via immunostaining of acetylated
α-tubulin (Fig. 4a). The absence of noticeable differences
between pnttq209 and normal Sb zebrafish larvae suggests
that IF1 loss does not significantly affect the neurogenesis
of spinal cord motor neurons. Nonetheless, we carried out
a quantitative assay of larvae locomotion to assess whe-
ther motor neuron function was compromised. The total
distance moved by mutant and WT larvae, together with
their mean and maximum velocity, were analysed (Fig. 4b-
d). The assay demonstrated no significant motility
alteration of pnttq209 mutants, indicating that zebrafish
lacking Atpif1a does not exhibit typical signs of motor
neuron degeneration.
Discussion
This study examined the role of IF1 in the development of
the zebrafish nervous system during embryogenesis. Our
interest stemmed from the notion that IF1 expression,
which is maintained at high levels in adult neurons30,49,
undergoes timed regulation during differentiation and
maturation of stem cells24,50, suggesting a possible role for
the protein in vertebrate development. This hypothesis
appears to be confirmed by the defects in erythroblast dif-
ferentiation associated with Atpif1a loss in zebrafish, which
cause a severe form of sideroblastic anaemia14. Nonetheless,
little is still known about the effect of pathological altera-
tions in IF1 expression during embryogenesis. The zebrafish
is an extremely valuable model system for studying verte-
brate biology, also enabling developmental genetic and
functional studies51. Moreover, considering the high level of
conservation of genetic sequences, molecular processes and
organ systems between zebrafish and other vertebrates,
including humans, zebrafish is emerging as preferred model
for studying developmental pathology52. In this work, the
use of the pnttq209 zebrafish mutant allowed the identifica-
tion of alterations in the neural system, attributable to loss
of Atpif1a expression. Specifically, we detected cell loss (i),
induction of a pro-inflammatory environment (ii) and
vision impairment (iii).
During brain maturation, apoptosis plays a key role and
any defect in the process, such as irregular, premature
and/or excessive apoptosis, can lead to neurodegenera-
tion53. We recently reported that the level of IF1 expres-
sion defines the cellular response to apoptotic stress
preventing cellular demise22,26. Here we found that the
pnttq209 mutant zebrafish is characterized by a significant
increase in the number of apoptotic bodies in both brain
and retina, even though no significant alterations were
observed in the pattern of differentiated neurons between
mutant and WT larvae (Fig. 1).
The abnormal levels of apoptosis that characterize
pnttq209 zebrafish seem to have an impact on the activity
of microglial cells, which represent the resident macro-
phages of the CNS and are involved in the maintenance of
(see figure on previous page)
Fig. 3 Atpif1 deficiency causes a decline in the retinal expression of OPA1. a, b Fluorescent IHC of whole-mount 72 hpf zebrafish, stained with
anti-OPA1 antibody. Representative images (a) and quantification of OPA1 fluorescence intensity (b) are reported, showing a reduction in the OPA1
expression levels in the brain and retina of pnttq209 larvae (OPA1 fluorescence (A.U.), Sb: 1.00 ± 0.01, pnttq209: 0.70 ± 0.09; results are presented as mean
± S.E.M. (n= 3)). c, d Analysis of eye morphology in Sb and pnttq209 zebrafish obtained through anti-acetylated α-tubulin IHC of whole-mount 72 hpf
zebrafish. No major morphological differences were observed between normal and mutant larvae, as shown in the prototypical images (c) and
relative quantification of eye size (d) (eye size (pixels), Sb: 2.58 ± 0.10, pnttq209: 2.53 ± 0.06; results are presented as mean ± S.E.M. (n= 10)).
e, f Quantification of OPA1 levels via western blotting analysis in 72 hpf wild type and pnttq209 larvae. The representative membrane blotted for both
OPA1 isoform (e) and the bar chart (f) show a significant decrease in the levels of the short isoform of the protein in pnttq209 larvae. g–j (OPA1 band
density relative to ACTB, OPA1 long isoform Sb: 1.00 ± 0.01, pnttq209:0.97 ± 0.01; OPA1 short isoform Sb: 1.00 ± 0.01, pnttq209:0.84 ± 0.01; results are
presented as mean ± S.E.M. (n= 3), Quantitative western blot analysis of OPA1 levels in the brain (frontal cortex/hippocampus) (j, k) and isolated
optic nerve (l, m) of WT and Atpif1−/− mice. Representative blots (j, l) and quantitated band densities relative to GAPDH (k, m) are reported.
Significantly lower levels of short and long OPA1 isoforms expression were found in the brain and, specifically, in the optic nerve of mutant mice
(OPA1 band density relative to GAPDH, OPA1 long isoform WT: 1.00 ± 0.01, Atpif1−/−: 0.52 ± 0.01 in the frontal cortex/hippocampus; in the optic
nerve, WT: 1.00 ± 0.05, Atpif1−/−: 0.59 ± 0.09; in the frontal cortex/hippocampus OPA1 short isoform WT: 1.00 ± 0.01, Atpif1−/−: 0.68 ± 0.01; in the optic
nerve, WT: 1.00 ± 0.05, Atpif1−/−: 0.548 ± 0.01; results are presented as mean ± S.E.M. (n= 3). FB forebrain, HB hindbrain, MB midbrain, NR neural
retina, L lens
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cell homeostasis by clearing dead and dysfunctional
neurons. pnttq209 zebrafish are characterized by higher
microglial activity (Fig. 1), which can be a direct con-
sequence of the increased programmed demise both in
the brain and retina of pnttq209 mutants. Though micro-
glia play a neuroprotective role36, their excessive activity is
frequently observed in damaged brain tissues and neu-
rodegenerative disorders38,54.
By using specific microglial markers, we identified an
increase in both number and size of microglial cells in
pnttq209 mutant zebrafish confirming that phagocytic
activity of microglia is enhanced in the absence of Atpif1a
and causes neuroinflammatory damage. Notably, acti-
vated microglial cells are localized at high levels in the
retina of the larvae (Fig. 1).
The concomitant rise in both cell death and microglia-
induced neuroinflammation detected in the retina of
pnttq209 larvae suggests that organ function may also be
compromised. By testing the OKR of pnttq209 larvae
(Fig. 2), we gained evidence that IF1 deficiency associates
with visual impairment noting a significant reduction in
retinal movements triggered by changes in the sur-
rounding environment (Fig. 2). A decline in visual acuity
was also observed in Atipif1−/− mice, corroborating that
IF1 may have a conserved role in the development of
vertebrate vision (Fig. 2).
The retinal photoreceptor cells, which comprise two
different types of neurons, cones and rods, both specialized
in phototransduction, are metabolically active cells char-
acterized by high-mitochondrial content55,56. Tissues with
high-energy demand, such as the neural retina, are fre-
quently affected by the presence of mutations in genes that
encode for mitochondrial proteins57. The impairments in
visual capacity caused by IF1 deficiency in zebrafish and
mouse may be therefore related to retinal mitochondrial
alterations. Indeed, IF1 controls different aspects of mito-
chondrial homeostasis6,20,26,58 and mitochondrial defects
are commonly associated with eye disorders59.
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Fig. 4 pnttq209 zebrafish show normal development of the spinal cord and locomotor ability. a Anti-acetylated α-tubulin IHC of whole-mount
72-hpf zebrafish. No marked differences in axonal growth and morphology were observed between Sb and pnttq209 larvae. Images were acquired at
three different focal planes to visualize the lateral line (F1) and the ventral and dorsal motor axons (F2 and F3, respectively). b–d Locomotor activity
assay in 72-hpf zebrafish. Total distance moved (b), mean velocity (c) and maximum velocity (d) were measured (average total distance moved (mm),
Sb: 18.39 ± 8.60, pnttq209: 21.22 ± 8.46; average mean velocity (mm/s), Sb: 0.02 ± 0.01, pnttq209: 0.05 ± 0.03; average maximum velocity (mm/s), Sb: 41.57
± 15.74, pnttq209: 42.47 ± 12.62; results are reported as mean ± S.E.M. (n= 9)). No variances were observed between Sb and pnttq209 larvae
Martín-Jiménez et al. Cell Death and Disease  (2018) 9:669 Page 8 of 13
Official journal of the Cell Death Differentiation Association
A mitochondrial protein that is highly involved in verte-
brate embryonic development is the dynamin-like GTPase
OPA160,61. OPA1, which exists as long, inner membrane-
bound, and short, soluble, isoforms, forms high-molecular
weight complexes that localize at the cristae junctions and
control both the fusion of the inner membranes of two
merging mitochondria and the shaping of mitochondrial
cristae62. OPA1 also plays a prominent part in cristae
remodelling and cytochrome c release during apoptosis63.
Recently, we discovered that IF1 has similar activity that
relies on stabilization of the mitochondrial ultrastructure22,
a function that exerted in coordination with OPA147.
Alterations in mitochondrial dynamics and metabolism
have been previously proposed as a possible mechanism of
the OPA1-type ADOA pathogenesis64. Moreover, OPA1
deficiency causes developmental defects in zebrafish,
including abnormal cardiac function and blood circula-
tion60. With our study, we provide further proof of shared
pathological mechanisms between IF1 and OPA1. Both are
highly expressed in the developing vertebrate brain and
retina43–45,65 and we learnt that IF1 interplays with OPA1 in
the control of mitochondrial adaptation to programmed cell
death46. Here we show that impairment of this relay, which
is core to mitochondrial structure and functions affects the
visual capacity in both models of analysis leaving unaffected
other parametres such as the locomotion at least at the state
of analysis here adoboted66,67.
Beyond the pathophysiological outcome, which we
linked to OPA1, the modifications in the mitochondrial
complexes and SCs assembly recorded via the in-gel
analysis corroborate how IF1 is intimately linked with
mitochondrial OXPHOS homeostasis (S Figs. 1 and 2)
beyond the preservation of ATP pools during reversion of
the ATPsynthase28.
Though in zebrafish the loss of IF1 induces detectable
alterations solely in their visual capacity, we cannot
exclude endogenous compensatory mechanisms mediated
by the Atpif1a-related paralogue, Atpif1b, which might
reduce or mask the effects of the IF1 loss in other tissues.
However, the lethal phenotype of the double Atpif1a/b
KO zebrafish mutant6 prevented further in-depth analysis.
The merit of this work does lie in its capacity to reveal
how IF1 takes part the developmental of central nervous
system widening the relevance of this mitochondrial
protein (see working model depicted in Fig. 5) beyond the
pathological processes to which it is prevalently
associated26,32,68.
Materials and methods
Animal models
Zebrafish were housed in a multi-rack aquarium system
at the Royal Veterinary College and kept on a constant 14/
10 h light/dark cycle at 27–29 °C69. The pnttq209 mutant
zebrafish line6 was obtained from the Tübingen Stock
OPA1 EXPRESSION
APOPTOSIS
NEUROINFLAMMATION 
ATPIF1
DEVELOPING CNS VISUAL IMPAIRMENTSRETINAL NEURONAL CELL DEATH
NEURAL RETINA
GANGLION
CELLS
PHOTORECEPTOR
CELLS
Fig. 5 Involvement of IF1 in vertebrate eye development. The loss of IF1 activity causes abnormally high apoptosis and microglial activation in the
CNS and retina during zebrafish embryogenesis, an event which suggests increased levels of neuroinflammation. IF1 deficiency is also associated with
a marked decline in the brain and retinal levels of OPA1, the expression of which is fundamental for guaranteeing the correct development of the
vertebrate eye. As a consequence, IF1 KO zebrafish and mouse models are both characterized by mild visual impairment that does not interfere with
the normal animal functions, and which is possibly caused by apoptosis- and neuroinflammation-mediated neuro-retinal damage
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Center. Zebrafish embryos, obtained by natural spawning,
were examined and manually dechorionated under a
Nikon SMZ1500 microscope (Nikon, Kingston upon
Thames, UK). To prevent pigmentation, embryos were
raised in water containing 0.003% 1-phenyl-2-thiourea
(PTU), starting at 24 hpf. At 72 hpf, larvae were categor-
ized as either normal Sb or pnttq209 mutants depending on
their phenotype6. All zebrafish experiments were locally
ethically approved by the Royal Veterinary College, and
nationally approved by the UK Home Office under the
Animal (Scientific Procedures) Act 1986.
C57 BL/6 (WT) and C57/BL6J (Atpif1−/−) mice47 were
used in accordance with national and European (86/609/
EEC) guidelines.
TUNEL and anti-HuC/D immunofluorescence double-
labelling assay
DeadEnd™ Fluorometric TUNEL System (Promega,
G3250) was used for the specific detection and quantita-
tion of apoptotic cells in PTU-treated and dechorionated
72 hpf zebrafish. The catalytic incorporation of
fluorescein-12-dUTP at 3′-OH DNA ends was developed
following the principle of the TUNEL (TdT-mediated
dUTP Nick-End Labelling) assay and the manufacturer
recommendations. Briefly, 72 hpf zebrafish were fixed in
4% paraformaldehyde (PFA) in PBS (overnight incubation
at 4 °C). After fixation, larvae were washed three times in
PBS+ 0.1% Triton™ X-100 (PBT) and then subjected to
proteinase K (Sigma-Aldrich, P2308) digestion (15 ng/ml
for 1 h in PBT). Subsequently, larvae were fixed for 20 min
in 4% PFA in PBS, blocked in equilibration buffer for 30
min, and finally incubated for 1 h at 37 °C in TdT reaction
mix (equilibration buffer+ nucleotide mix and rTdT
enzyme in a 5:1 ratio). Unincorporated fluorescein-12-
dUTP was removed through three washes in PBT. After
TUNEL assay was performed, larvae were incubated for 1
h at room temperature in blocking solution (10% normal
goat serum plus 1% dimethyl sulphoxide in PBT), and
then overnight at 4 °C with a mouse anti-HuC/D antibody
(1:1000; Molecular Probes, A21271). Following several
washes in PBT, the larvae were incubated overnight at 4 °C
with a goat anti-mouse Alexa Fluor®568-conjugated anti-
body (1:400; Invitrogen, A11004). Fluorescently-labelled
larvae were imaged using a laser-scanning confocal micro-
scope (LeicaTM SP5). All images were acquired without
changing the microscope settings and processed in the
same way. The number of apoptotic bodies in the brain and
retina was quantified using ImageJ software (NIH).
Immunohistochemistry (IHC) of whole-mount zebrafish
larvae
IHC was performed in whole-mount PTU-treated and
dechorionated 72 hpf zebrafish as previously described70.
Larvae immunostained with anti-acetylated α-tubulin
(1:1000; Sigma-Aldrich, T7451)70 were imaged with a
Zeiss Axiovert inverted microscope.
For anti-OPA1 fluorescent IHC, PTU-treated and
dechorionated 72 hpf zebrafish were fixed in 4% PFA in
PBS and treated with proteinase K (15 ng/ml for 1 h in
PBS+ 0.1% Triton™ X-100). After leaving the larvae in
blocking solution for 1 h, they were incubated overnight at
4 °C with a mouse anti-OPA1 antibody (1:500; BD Bios-
ciences, 612607). Following a wash in PBT for several
hours, larvae were then incubated overnight at 4 °C with a
goat anti-mouse Alexa Fluor®568-conjugated antibody
(1:400; Invitrogen, A11004). Larvae were cleared in 70%
glycerol in PBS and imaged with a laser-scanning confocal
microscope (LeicaTM SP5). OPA1 fluorescent intensity
was quantified using ImageJ software.
NR assay
Microglial cells were detected in living dechorionated
zebrafish larvae by staining with NR, a vital dye that is
accumulated in the lysosomes through endocytosis35.
PTU-treated and dechorionated 56 hpf zebrafish were
incubated in the dark overnight (to reach the larval stage)
at 28–30 °C in 2.5 μg/mL NR solution. After two rinses
with fish water, larvae were fixed in 2% low melting-point
agarose in fish water. Live imaging was carried out using a
Zeiss Axiovert inverted microscope. The number and size
of NR-positive cells in the brain and retina were quanti-
fied using ImageJ software.
Whole-mount ISH of apoE mRNA
ISH was carried out on PTU-treated and dechorionated
72 hpf zebrafish using an apoE riboprobe (a generous gift
from Dr. Francesca Peri, European Molecular Biology
Laboratory, Heidelberg, Germany), as previously descri-
bed36. The number of apoE-positive cells in the brain and
retina was quantified using ImageJ software (NIH).
Western blot analysis of mouse brain extracts
Four-month-old mice were killed by cervical dislocation
and, prior to dissection, sterilized with ethanol. The skull was
opened to release the brain, which was immediately stored
on ice. The frontal cortex, hippocampus and optic nerve
were then isolated and lysed in radioimmunoprecipitation
assay buffer (50Mm Tris, 150mM NaCl, 1mM EDTA, 5
mM MgCl2, 1% Triton™ X-100, 0.25% sodium deoxycholate,
0.1% SDS, pH 7.4) supplemented with protease/phosphatase
inhibitors (Roche Diagnostics, 04693132001). The lysates
obtained from the frontal cortex and hippocampus were then
combined. The lysates were sonicated and centrifuged at
17,000×g at 4 °C for 20min, after which the supernatants
were collected and stored at −80 °C.
The protein concentration was estimated using a BCA
protein assay reagent (Thermo Scientific). Equal amounts
of protein (20 μg) were resolved in 8% polyacrylamide gel
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and transferred to nitrocellulose membrane. The mem-
brane was blocked in 3% non-fat dry milk in TBST (50
mM Tris, 150 mM NaCl, 0.05% Tween 20 (Sigma-
Aldrich), pH 7.5) for 1 h and then incubated with the
appropriate diluted primary antibody at 4 °C overnight:
mouse anti-OPA1 (1:1000; BD Biosciences, 612607),
mouse anti-GAPDH (1:10000; Abcam, ab 8245). After
three washes in TBST, the membrane was incubated with
goat anti-mouse HRP-conjugated antibody for 1 h at
room temperature. Amersham ECL Prime Western
Blotting Detection Reagent kit (GE Healthcare Life Sci-
ences, RPN2232) was used to develop the membrane.
Immunoreactive bands were analysed with ImageJ soft-
ware (NIH).
In-gel analysis of mitochondrial respirasomes
The method was adapted from Nijtmans et al.71, Wittig
et al.72 and Calvaruso et al.73. Mice were killed by cervical
dislocation. Then, brain and liver tissues were collected
on ice and homogenized using a glass-Teflon potter
homogenizer in mitochondrial isolation buffer (440 mM
sucrose, 20 mM Mops, 1 mM EDTA) with 0.2 mM phe-
nylmethylsulfonyl fluoride. Protein extracts were sepa-
rated by Blue Native Bis-Tris PAGE 4–16% (NativePage
Thermo Fisher scientific).
Homogenates were centrifuged at 20,000×g for 15 min
at 4 °C. After that the pellet was homogenized in a solu-
tion composed of 1M aminocaproic acid and 50mM Bis-
Tris-HCL pH 7.0. Digitonin 4mg/mL was added to the
homogenate and incubated for 20 min on ice. After cen-
trifugation at 100,000×g for 15 min, the supernatant was
collected and combined with Serva blue G 5% in 1M
aminocaproic acid.
The Coomassie Blue Staining was obtained by immer-
sing the gels in staining solution 0.1% Serva G in 40%
methanol for 30min at room temperature. Then the
staining solution was removed and the gels were incubated
with destaining solution 40% methanol and 10% acetic
acid for 30min twice. At this point the gels were scanned.
Locomotor activity assay
Dechorionated 72 hpf zebrafish were individually placed
into the wells of a 96-well plate. A DMx21AF04 digital
camera was used with Noldus 2010 Media Recorder software
to record 20min videos with a frame rate of 30 frames/s and
640 × 480 resolution. The videos were processed using
EthoVision XT8 software (Noldus) to track the movements of
each zebrafish larva. Quantitive data was produced using
three movement parameters: total distance moved (mm),
mean velocity (mm/s) and maximum velocity (mm/s).
OKR measurements
Three minute, 30 fps digital recordings of 72 hpf zeb-
rafish were taken using a DMx21AF04 digital camera with
Noldus 2010 Media Recorder software. Each animal was
recorded with and without a moving striped visual back-
ground made from black and white cards, where each
stripe was ~2 cm thick. In recordings using the striped
visual background, card was rotated around the 96-well
plate in small back and forth movements in quick suc-
cession. One retinal movement includes one or both
retinae.
Visual cliff test
Visual acuity was tested in C57 BL/6 (WT) and C57/
BL6J Atpif1−/−mice using the visual cliff test according to
Carlezon and colleagues74. The apparatus comprised a 1
m height checkered pattern platform covered with a clear
piece of acrylic glass, extended by 50 cm from the edge of
the platform, and a checkered pattern sheet positioned
below the extending glass. A raised dais was placed
between the platform and the extending glass, creating the
illusion of a cliff. Each mouse was placed on the raised
dais and allowed to step off to either the shallow side (safe
choice) or the deep side (unsafe choice). Each mouse was
tested in ten trials, and choices were manually recorded as
safe if the mouse stepped towards the platform and unsafe
if the mouse stepped towards the extending acrylic glass.
Statistics
Statistical analyses were performed using GraphPad
Prism 6 software. Two groups were compared using the
unpaired t-test. Comparison of three or more groups was
performed by one-way ANOVA. A p-value <0.05 was
considered significant.
Acknowledgements
Thank you to all members of the Claire Russell and Michelangelo Campanella
research groups for the ongoing support.
The research led by C.R. was funded as follows: E.A. and H.B.R. were
undergraduate project students supported by bench fees from UCL and RVC;
L.A. was an undergraduate summer student visiting from the Universidad
Autónoma de Madrid; R.M.-J. is a postdoctoral researcher funded by a research
grant to C.R. and M.C. from SPARKS children’s charity.
The research activities led by M.C. are supported by the following funders,
which are gratefully acknowledged: Biotechnology and Biological Sciences
Research Council (grant numbers BB/M010384/1 and BB/N007042/1); the
Medical Research Council [grant number G1100809/2], Bloomsbury Colleges
Consortium PhD Studentship Scheme; The Petplan Charitable Trust; Umberto
Veronesi Foundation Young Investigator Research Programme; Marie Curie
Actions [TSPO & Brain (304165)], LAM-Bighi Grant Initiative. FIRB-Research Grant
Consolidator Grant 2 [grant number: RBFR13P392], Italian Ministry of Health
[IFO14/01/R/52].
The greatest acknowledgement of all should go to the late Prof. Barry Paw
who called for our attention on the zebrafish mutant, pinotage (pnttq209). This
work is therefore dedicated to his vision, collaborative spirit and now living
memory.
Author details
1Department of Comparative Biomedical Sciences, Royal Veterinary College,
NW1 0TU London, United Kingdom. 2Department of Biology, University of
Rome Tor Vergata, 00144 Rome, Italy. 3IRCCS- Regina Elena, National Cancer
Institute, 00133 Rome, Italy. 4University College London Consortium for
Mitochondrial Research, University College London, WC1 6BT London, United
Kingdom
Martín-Jiménez et al. Cell Death and Disease  (2018) 9:669 Page 11 of 13
Official journal of the Cell Death Differentiation Association
Author contributions
M.C. and C.R. designed and coordinated the experiments. M.C. supervised the
work on murine models run by D.F., C.F. and D.S., whilst C.R. supervised those
on zebrafish experiments performed by R.M.-J., E.A., H.B.R. and L.A. R.M.-J.
carried out zebrafish TUNEL, immunofluorescence and western blot
experiments, with aid from L.A. for the OPA1 IHC. apoE ISH and NR stain were
performed by H.B.R. with analysis by D.F. The zebrafish functional assays were
executed by E.A. Figures were finalised by D.F. D.F., R.M.-J., C.R. and M.C.
contributed to manuscript preparation. Funding was secured by C.R. and M.C.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Supplementary Information accompanies this paper at https://doi.org/
10.1038/s41419-018-0578-x.
Received: 25 October 2016 Revised: 21 March 2018 Accepted: 27 March
2018
References
1. Martin-Jimenez, R., Campanella, M. & Russell, C. New zebrafish models of
neurodegeneration. Curr. Neurol. Neurosci. Rep. 15, 33 (2015).
2. Pinho, B. R. et al. How mitochondrial dysfunction affects zebrafish develop-
ment and cardiovascular function: an in vivo model for testing mitochondria-
targeted drugs. Br. J. Pharmacol. 169, 1072–1090 (2013).
3. Ivanes, F. et al. The compound BTB06584 is an IF1 -dependent selective
inhibitor of the mitochondrial F1 Fo-ATPase. Br. J. Pharmacol. 171, 4193–4206
(2014).
4. Lo, C., Flinn, L. J. & Bandmann, O. Heterozygous mutations in the FGF8, SHH
and nodal/transforming growth factor beta pathways do not confer increased
dopaminergic neuron vulnerability--a zebrafish study. Neurosci. Lett. 532,
55–58 (2013).
5. Zdebik, A. A. et al. Epilepsy in kcnj10 morphant zebrafish assessed with a novel
method for long-term EEG recordings. PLoS ONE 8, e79765 (2013).
6. Shah, D. I. et al. Mitochondrial Atpif1 regulates haem synthesis in developing
erythroblasts. Nature 491, 608–612 (2012).
7. DiMauro, S. Mitochondrial diseases. Biochim. Biophys. Acta 1658, 80–88
(2004).
8. Birket, M. J. et al. A reduction in ATP demand and mitochondrial activity with
neural differentiation of human embryonic stem cells. J. Cell Sci. 124, 348–358
(2011).
9. O’Brien, L. C., Keeney, P. M. & Bennett, J. P. Jr. Differentiation of human neural
stem cells into motor neurons stimulates mitochondrial biogenesis and
decreases glycolytic flux. Stem Cells Dev. 24, 1984–1994 (2015).
10. Wilson, T. J., Slupe, A. M. & Strack, S. Cell signaling and mitochondrial dynamics:
Implications for neuronal function and neurodegenerative disease. Neurobiol.
Dis. 51, 13–26 (2013).
11. Yoshida, M., Muneyuki, E. & Hisabori, T. ATP synthase--a marvellous rotary
engine of the cell. Nat. Rev. Mol. Cell Biol. 2, 669–677 (2001).
12. Davies, K. M., Anselmi, C., Wittig, I., Faraldo-Gomez, J. D. & Kuhlbrandt, W.
Structure of the yeast F1Fo-ATP synthase dimer and its role in shaping the
mitochondrial cristae. Proc. Natl Acad. Sci. USA 109, 13602–13607 (2012).
13. Bonora, M. et al. Molecular mechanisms of cell death: central implication of
ATP synthase in mitochondrial permeability transition. Oncogene 34,
1475–1486 (2015).
14. Hejzlarova, K. et al. Nuclear genetic defects of mitochondrial ATP synthase.
Physiol. Res. 63, S57–S71 (2014).
15. Chinnery, P. F. Mitochondrial Disorders Overview GeneReviews® [Internet].
(Seattle, WA: University of Washington, Seattle; 1993-2018).
16. Veas-Perez de Tudela, M. et al. Regulation of Bcl-xL-ATP synthase interaction
by mitochondrial cyclin B1-cyclin-dependent kinase-1 determines neuronal
survival. J. Neurosci. 35, 9287–9301 (2015).
17. Daum, B., Walter, A., Horst, A., Osiewacz, H. D. & Kuhlbrandt, W. Age-dependent
dissociation of ATP synthase dimers and loss of inner-membrane cristae in
mitochondria. Proc. Natl Acad. Sci. USA 110, 15301–15306 (2013).
18. Faccenda, D. & Campanella, M. Molecular regulation of the mitochondrial F(1)F
(o)-ATPsynthase: physiological and pathological significance of the inhibitory
factor 1 (IF(1)). Int J. Cell Biol. 2012, 367934 (2012).
19. Garcia-Bermudez, J. & Cuezva, J. M. The ATPase inhibitory factor 1 (IF1): a
master regulator of energy metabolism and of cell survival. Biochim. Biophys.
Acta 1857, 1167–1182 (2016).
20. Domenis, R., Bisetto, E., Rossi, D., Comelli, M. & Mavelli, I. Glucose-modulated
mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor
Factor 1. Int. J. Mol. Sci. 13, 1933–1950 (2012).
21. Sanchez-Arago, M., Formentini, L., Garcia-Bermudez, J. & Cuezva, J. M. IF1
reprograms energy metabolism and signals the oncogenic phenotype in
cancer. Cell Cycle 11, 2963–2964 (2012).
22. Faccenda, D., Tan, C. H., Duchen, M. R. & Campanella, M. Mitochondrial IF(1)
preserves cristae structure to limit apoptotic cell death signaling. Cell Cycle 12,
2530–2532 (2013).
23. Matic, I., Strobbe, D., Frison, M. & Campanella, M. Controlled and impaired
mitochondrial quality in neurons: molecular physiology and prospective
pharmacology. Pharmacol. Res. 99, 410–424 (2015).
24. Sanchez-Arago, M., Garcia-Bermudez, J., Martinez-Reyes, I., Santacatterina, F. &
Cuezva, J. M. Degradation of IF1 controls energy metabolism during osteo-
genic differentiation of stem cells. EMBO Rep. 14, 638–644 (2013).
25. Genoux, A. et al. Mitochondrial inhibitory factor 1 (IF1) is present in human
serum and is positively correlated with HDL-cholesterol. PLoS ONE 6, e23949
(2011).
26. Faccenda, D., Tan, C. H., Seraphim, A., Duchen, M. R. & Campanella, M. IF1 limits
the apoptotic-signalling cascade by preventing mitochondrial remodelling.
Cell Death Differ. 20, 686–697 (2013).
27. Formentini, L., Sanchez-Arago, M., Sanchez-Cenizo, L. & Cuezva, J. M. The
mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde
prosurvival and proliferative response. Mol. Cell. 45, 731–742 (2012).
28. Campanella, M. et al. Regulation of mitochondrial structure and function by
the F1Fo-ATPase inhibitor protein, IF1. Cell Metab. 8, 13–25 (2008).
29. Volkenhoff, A. et al. Glial glycolysis is essential for neuronal survival in Droso-
phila. Cell Metab. 22, 437–447 (2015).
30. Formentini, L. et al. In vivo inhibition of the mitochondrial H+-ATP synthase
in neurons promotes metabolic preconditioning. EMBO J. 33, 762–778
(2014).
31. Fox, M. W. The visual cliff test for the study of visual depth perception in the
mouse. Anim. Behav. 13, 232–233 (1965).
32. Matic, I. et al. Neuroprotective coordination of cell mitophagy by the ATPase
Inhibitory Factor 1. Pharmacol. Res. 103, 56–68 (2016).
33. Sanchez-Arago, M. et al. Expression, regulation and clinical relevance of the
ATPase inhibitory factor 1 in human cancers. Oncogenesis 2, e46 (2013).
34. Postlethwait, J. H. et al. Vertebrate genome evolution and the zebrafish gene
map. Nat. Genet. 18, 345–349 (1998).
35. Herbomel, P., Thisse, B. & Thisse, C. Zebrafish early macrophages colonize
cephalic mesenchyme and developing brain, retina, and epidermis through
a M-CSF receptor-dependent invasive process. Dev. Biol. 238, 274–288
(2001).
36. Peri, F. & Nusslein-Volhard, C. Live imaging of neuronal degradation by
microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell
133, 916–927 (2008).
37. Kozlowski, C. & Weimer, R. M. An automated method to quantify microglia
morphology and application to monitor activation state longitudinally in vivo.
PLoS ONE 7, e31814 (2012).
38. Perry, V. H. & Holmes, C. Microglial priming in neurodegenerative disease. Nat.
Rev. Neurol. 10, 217–224 (2014).
39. Madeira, M. H., Boia, R., Santos, P. F., Ambrosio, A. F. & Santiago, A. R. Con-
tribution of microglia-mediated neuroinflammation to retinal degenerative
diseases. Mediat. Inflamm. 2015, 673090 (2015).
40. Brockerhoff, S. E. et al. A behavioral screen for isolating zebrafish mutants with
visual system defects. Proc. Natl Acad. Sci. USA 92, 10545–10549 (1995).
41. Alexander, C. et al. OPA1, encoding a dynamin-related GTPase, is mutated in
autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet.
26, 211–215 (2000).
42. Delettre, C. et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-
related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207–210
(2000).
Martín-Jiménez et al. Cell Death and Disease  (2018) 9:669 Page 12 of 13
Official journal of the Cell Death Differentiation Association
43. Diez-Roux, G. et al. A high-resolution anatomical atlas of the transcriptome in
the mouse embryo. PLoS Biol. 9, e1000582 (2011).
44. Magdaleno, S. et al. BGEM: an in situ hybridization database of gene
expression in the embryonic and adult mouse nervous system. PLoS Biol. 4,
e86 (2006).
45. Aijaz, S., Erskine, L., Jeffery, G., Bhattacharya, S. S. & Votruba, M. Developmental
expression profile of the optic atrophy gene product: OPA1 is not localized
exclusively in the mammalian retinal ganglion cell layer. Invest. Ophthalmol. Vis.
Sci. 45, 1667–1673 (2004).
46. Faccenda, D. et al. Control of mitochondrial remodeling by the ATPase inhi-
bitory factor 1 unveils a pro-survival relay via OPA1. Cell Rep. 18, 1869–1883
(2017).
47. Nakamura, J., Fujikawa, M., Yoshida, M. IF1, a natural inhibitor of mitochondrial
ATP synthase, is not essential for the normal growth and breeding of mice.
Biosci. Rep. 33, e00067 (2013).
48. Delettre, C., Lenaers, G., Pelloquin, L., Belenguer, P. & Hamel, C. P. OPA1 (Kjer
type) dominant optic atrophy: a novel mitochondrial disease. Mol. Genet.
Metab. 75, 97–107 (2002).
49. Campanella, M., Parker, N., Tan, C. H., Hall, A. M. & Duchen, M. R. IF(1): setting
the pace of the F(1)F(o)-ATP synthase. Trends Biochem. Sci. 34, 343–350 (2009).
50. Vazquez-Martin, A. et al. The mitochondrial H(+)-ATP synthase and the lipo-
genic switch: new core components of metabolic reprogramming in induced
pluripotent stem (iPS) cells. Cell Cycle 12, 207–218 (2013).
51. Ingham, P. W. Zebrafish genetics and its implications for understanding ver-
tebrate development. Hum. Mol. Genet. 6, 1755–1760 (1997).
52. Lieschke, G. J. & Currie, P. D. Animal models of human disease: zebrafish swim
into view. Nat. Rev. Genet. 8, 353–367 (2007).
53. Okouchi, M., Ekshyyan, O., Maracine, M. & Aw, T. Y. Neuronal apoptosis in
neurodegeneration. Antioxid. Redox Signal. 9, 1059–1096 (2007).
54. Luo, X. G., Ding, J. Q. & Chen, S. D. Microglia in the aging brain: relevance to
neurodegeneration. Mol. Neurodegener. 5, 12 (2010).
55. Ames, A. 3rd, Li, Y. Y., Heher, E. C. & Kimble, C. R. Energy metabolism of rabbit
retina as related to function: high cost of Na+transport. J. Neurosci. 12,
840–853 (1992).
56. Okawa, H., Sampath, A. P., Laughlin, S. B. & Fain, G. L. ATP consumption by
mammalian rod photoreceptors in darkness and in light. Curr. Biol. 18,
1917–1921 (2008).
57. Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283,
1482–1488 (1999).
58. Barbato, S., Sgarbi, G., Gorini, G., Baracca, A. & Solaini, G. The inhibitor protein
(IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics. J.
Biol. Chem. 290, 6338–6348 (2015).
59. Schrier, S. A. & Falk, M. J. Mitochondrial disorders and the eye. Curr. Opin.
Ophthalmol. 22, 325–331 (2011).
60. Rahn, J. J., Stackley, K. D. & Chan, S. S. Opa1 is required for proper mito-
chondrial metabolism in early development. PLoS ONE 8, e59218 (2013).
61. Olichon, A. et al. Mitochondrial dynamics and disease, OPA1. Biochim. Biophys.
Acta 1763, 500–509 (2006).
62. Hoppins, S. & Nunnari, J. The molecular mechanism of mitochondrial fusion.
Biochim. Biophys. Acta 1793, 20–26 (2009).
63. Frezza, C. et al. OPA1 controls apoptotic cristae remodeling independently
from mitochondrial fusion. Cell 126, 177–189 (2006).
64. Olichon, A. et al. Effects of OPA1 mutations on mitochondrial morphology and
apoptosis: relevance to ADOA pathogenesis. J. Cell Physiol. 211, 423–430
(2007).
65. Thisse, B. et al. Spatial and temporal expression of the zebrafish genome by
large-scale in situ hybridization screening. Methods Cell Biol. 77, 505–519
(2004).
66. Saint-Amant, L. & Drapeau, P. Time course of the development of motor
behaviors in the zebrafish embryo. J. Neurobiol. 37, 622–632 (1998).
67. Brustein, E. et al. Steps during the development of the zebrafish locomotor
network. J. Physiol. Paris. 97, 77–86 (2003).
68. Rouslin, W. & Pullman, M. E. Protonic inhibition of the mitochondrial adenosine
5’-triphosphatase in ischemic cardiac muscle. Reversible binding of the ATPase
inhibitor protein to the mitochondrial ATPase during ischemia. J. Mol. Cell.
Cardiol. 19, 661–668 (1987).
69. Westerfield, M. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish
(Danio rerio). (Univ of Oregon Press, Oregon, 2007).
70. Concha, M. L., Burdine, R. D., Russell, C., Schier, A. F. & Wilson, S. W. A nodal
signaling pathway regulates the laterality of neuroanatomical asymmetries in
the zebrafish forebrain. Neuron 28, 399–409 (2000).
71. Nijtmans, L. G. J., Henderson, N. S. & Holt, I. J. Blue Native electrophoresis to
study mitochondrial and other protein complexes. Methods 26, 327–334
(2002).
72. Wittig, I., Braun, H. P. & Schagger, H. Blue native PAGE. Nat. Prot. 1, 418–428
(2006).
73. Calvaruso, M. A., Smeitink, J. & Nijtmans, L. Electrophoresis techniques to
investigate defects in oxidative phosphorylation. Methods 46, 281–287 (2008).
74. Van’t Veer, A. et al. Ablation of kappa-opioid receptors from brain dopamine
neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.
Neuropsychopharmacology 38, 1585–1597 (2013).
75. Lefebvre, V. et al. Genome-wide RNAi screen identifies ATPase inhibitory factor
1 (ATPIF1) as essential for PARK2 recruitment and mitophagy. Autophagy 9,
1770–1779 (2013).
Martín-Jiménez et al. Cell Death and Disease  (2018) 9:669 Page 13 of 13
Official journal of the Cell Death Differentiation Association
